Atomoxetine Hydrochloride

규격

82248-59-7CAS 번호

629-925-3EC 번호

(3R)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine;hydrochlorideIUPAC 명칭

C17H22ClNO화학식

291.8 g/mol분자량

Atomoxetine hydrochloride; 82248-59-7; Atomoxetine HCL; TOMOXETINE HYDROCHLORIDE; (R)-Tomoxetine hydrochloride; (R)-(-)-Tomoxetine hydrochloride; DTXSID2044266; LY-139603; Atomoxetine (as hydrochloride); 57WVB6I2W0; (-)-N-Methyl-3-phenyl-3-(o-tolyloxy)propylamine hydrochloride; NSC-759104; DTXCID0024266; CHEBI:331697; (-)-N-methyl-3-phenyl-3-(o-tolyloxy)-propylamine hydrochloride; HCl, Atomoxetine; RefChem:56722; Hydrochloride, Atomoxetine; ATOMXETINE HYROCHLORIDE; 139603, LY; (-)-N-methyl-gamma(2-methylphenoxy)benzenepropamine Hydrochloride; N-methyl-gamma-(2-methylphenoxy)benzenepropanamine hydrochloride; Strattera; (R)-N-Methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine hydrochloride; MFCD06410992; Atomoxetine hydrochloride [USAN]; Atomoxetine (hydrochloride); (3R)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine;hydrochloride; SMR000469177; LY-135252; CAS-82248-59-7; LY 139603; UNII-57WVB6I2W0; Strattera (TN); NCGC00016056-02; R-Tomexetine hydrochloride; C17H21ClNO; CHEMBL1702; Atomoxetine hydrochloride CRS; MLS001401377; MLS002153176; SCHEMBL122111; orb1223935; orb1310216; orb3141357; ATOMOXETINE HCL [VANDF]; SCHEMBL29528186; MSK10700A; LUCXVPAZUDVVBT-UNTBIKODSA-N; GLXC-07450; HMS3413C05; HMS3677C05; (R)-N-Methyl-3-phenyl-3-(o-tolyloxy)propan-1-aminehydrochloride; (R)-Tomoxetine hydrochloride, solid; Tox21_110292; Atomoxetine hydrochloride (JAN/USP); EBC-12895; HY-17385R; LY-139602 [(+)-isomer]; ATOMOXETINE HYDROCHLORIDE [MI]; (3R)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine hydrochloride; AKOS015920150; Benzenepropanamine, N-methyl-gamma-(2-methylphenoxy)-, hydrochloride, (-)-; Tox21_110292_1; Atomoxetine (hydrochloride) (Standard); ATOMOXETINE HYDROCHLORIDE [JAN]; CCG-100874; FM18010; KS-1223; NC00124; NSC 759104; ATOMOXETINE HYDROCHLORIDE [MART.]; NCGC00025345-02; ATOMOXETINE HYDROCHLORIDE [USP-RS]; ATOMOXETINE HYDROCHLORIDE [WHO-DD]; BM164222; HY-17385; SY053051; A2357; A7656; Atomoxetine hydrochloride - Bio-X trade mark; NS00076233; SW197504-3; Atomoxetine for impurity A identification CRS; ATOMOXETINE HYDROCHLORIDE [EP MONOGRAPH]; ATOMOXETINE HYDROCHLORIDE [ORANGE BOOK]; D02574; ATOMOXETINE HYDROCHLORIDE [USP MONOGRAPH]; EN300-18528139; F079413; SR-01000597779; SR-01000763397; SR-01000597779-1; SR-01000763397-3; Q27225729; F0001-2408; (R)-N-Methyl-(2-methylphenoxy)benzenepropanamine hydrochloride; Atomoxetine Hydrochloride 1.0 mg/ml in Methanol (as free base); (R)-N-Methyl-3-phenyl-3-(o-tolyloxy)-propan-1-amine hydrochloride; (R)-N-METHYL-3-PHENYL-3-(O-TOLYLOXY)PROPAN-1-AMINE HCL; methyl[(3R)-3-(2-methylphenoxy)-3-phenylpropyl]amine hydrochloride; (3R)-N-methyl-3-(2-methylphenoxy)-3-phenyl-propan-1-amine;hydrochloride; (R)-(-)-N-methyl-3-(2-methylphenoxy)-3-phenylpropylamine hydrochloride; (r)-n-methyl-gamma-(2-methylphenoxy)-benzenepropanamine hydrochloride; Atomoxetine hydrochloride, European Pharmacopoeia (EP) Reference Standard; METHYL-((R)-3-PHENYL-3-O-TOLYLOXY-PROPYL)-AMINE HYDROCHLORIDE; (3R)-N-Methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine--hydrogen chloride (1/1); (R)-(-)-N-Methyl-3-[(2-methylphenyl)oxy]-3-phenyl-1-aminopropane hydrochloride; Atomoxetine for impurity A identification, European Pharmacopoeia (EP) Reference Standard; Atomoxetine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material; Atomoxetine hydrochloride, United States Pharmacopeia (USP) Reference Standard; BENZENEPROPANAMINE, N-METHYL-.GAMMA.-(2-METHYLPHENOXY)-, HYDROCHLORIDE, (-); Benzenepropanamine, N-methyl-gamma-(2-methylphenoxy)-, hydrochloride (1:1), (gammaR)-동의어